Experiment 1308065

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

HEDERAGENIN-3-O-(3-4-DI-O-ACETYL-BETA-D-XYLOPYRANOSIDE(1-3)-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE)HEDERAGENIN-3-O-(2-O-ACETYL-BETA-D-XYLOPYRANOSIDE(1-3)-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE)HEDERAGENIN-3-O-(4-O-ACETYL-BETA-D-XYLOPYRANOSIDE(1-3)-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE)HEDERAGENIN-3-O-(2-4-DI-O-ACETYL-BETA-D-XYLOPYRANOSIDE(1-3)-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE)

Alerts

SEE ARTICLE FOR OTHER TEST RESULTS.

Details

PropertyValue
Pharmacology
TNF-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) RESISTANCE INHIBITION
OrganismSapindus trifoliatus (SAPINDACEAE)
CitationMIYAGAWA,T: OHTSUKI,T: KOYANO,T: KOWITHAYAKORN,T: ISHIBASHI,M:. (2009). CARDENOLIDE GLYCOSIDES OF THEVETIA PERUVIANA AND TRITERPENOID SAPONINS OF SAPINDUS EMARGINATUS AS TRAIL RESISTANCE-OVERCOMING COMPOUNDS. 72(8)
Amount utilized
Compound isolated
Dose amount<20 MICROMOLS
Number5
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED